Abnormal lipids and the acquired immunodeficiency syndrome: Is there a problem and what should we do about it?

International Journal of STD and AIDS

Volumn 10, Issue 6, 1999, Pages 353-356

  Crook, M A ^a,b   Mir, N ^a  

^a UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

AIDS; Cardiovascular disease; Insulin resistance; Lipids; Protease inhibitors

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; C REACTIVE PROTEIN; CREATINE KINASE; CYTOKINE; DIDANOSINE; FIBRIC ACID DERIVATIVE; FISH OIL; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDINAVIR; INSULIN; LIPID; LIPID HYDROPEROXIDE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; PROTEINASE INHIBITOR; RITONAVIR; STATIN; TRIACYLGLYCEROL; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE PANCREATITIS; CARDIOVASCULAR DISEASE; CELL TRANSPORT; CHOLESTEROL BLOOD LEVEL; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; FIBRINOLYSIS; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPOCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN RESISTANCE; LIPODYSTROPHY; LIPOGENESIS; LIPOLYSIS; LIVER DISEASE; LIVER FUNCTION; LIVER TOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RHABDOMYOLYSIS; SHORT SURVEY; SUBCUTANEOUS FAT; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CYTOKINES; HUMANS; LIPID METABOLISM; LIPOPROTEINS; LIPOPROTEINS, LDL; OXIDATIVE STRESS; PROTEASE INHIBITORS; TRIGLYCERIDES;

EID: 0032968750     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462991914212     Document Type: Short Survey

References (32)

1. Begin ME, Manku MS, Horrobin DF. Plasma fatty acid levels in patients with acquired immune deficiency syndrome and controls. Prostaglandins, Leukotrienes and Essential Fatty Acids 1989;37:135-7
2. Benhamou Y, Hilmarsdottir I, Despres-Livage, I, et al. Association of lipid accumulation in small intestinal mucosa with decreased serum triglyceride and cholesterol levels in AIDS. Dig Dis Sci 1994;39:2163-9
3. Shor-Posner G, Basit A, Lu Y, Cabrejos C, Chang J, Fletcher M. Hypocholesterolaemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med 1993;94:515-19
4. Falkenbach A, Klauke S, Althoff PH. Abnormalities in cholesterol metabolism cause peripheral neuropathy and dementia in AIDS: A hypothesis. Med Hypotheses 1990;33:57-61
5. Strittmatter C, Lang W, Wiestler OD, Kleihues P. The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: A study of 46 post-mortem cases. Acta Neuropathol 1992;83:475-81
6. Douvas GS, May MH, Pearson JR, Lam E, Miller L, Tsuchida N. Hypertriglyceridaemic serum, very low density lipoprotein and iron enhance Mycobacterium avium replication in human macrophages. J Infect Dis 1994;170:1248-55
7. Muga R, Tor J, Rey-Joly C, Pardo A, Llobet P, Foz M. Dyslipidaemia and HIV-1 infection in intravenous drug addicts (English abstract). Med Clin 1993;100:161-3
8. Constans J, Pellegrin JL, Peuchant E, et al. Plasma lipids in HIV infected patients: A prospective study in 95 patients. Eur J Clin Invest 1994;24:416-20
9. Grunfeld C, Kotler DP, Shigenaga JK, et al. Circulating interferon-alpha levels and hypertriglyceridaemia in the acquired immunodeficiency syndrome. Am J Med 1991;90:154-62
10. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992;74:1045-52
11. Feingold KR, Krauss RM, Pang M, Doerrler W, Jensen P, Grunfeld C. The hypertriglyceridaemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab 1993;76:1423-7
12. Hellerstein MK, Grunfeld C, Wu K, Christiansen M, Kaempfer S, Kletke C. Increased de novo hepatic lipogenesis in HIV-infected humans. J Clin Endocrinol Metab 1993;76:559-65
13. McLemore JL, Beeley P, Thorton K, Morrisoe K. Rapid automated determination of lipid hydroperoxide concentrations and total antioxidant status of samples from patients infected with HIV. Am J Clin Pathol 1998;109:268-73
14. Sullivan AK, Nelson MR. Marked hyperlipidaemia on ritonavir therapy. AIDS 1997;11:938-9
15. Eastone JA, Decker CF. New onset diabetes mellitus associated with use of protease inhibitor. Ann Intern Med 1997;127:948
16. Assman G, Schulte H. Relation of high density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster Study. Am J Cardiol 1992;70:733-7
17. Visnegarwala F, Kraue KL, Musher DM. Severe diabetes associated with protease inhibitor therapy. Ann Intern Med 1997;127:947
18. Anonymous. Protease inhibitors may raise blood glucose levels, FDA warns. Am J Health System Pharmacy 1997;54:1575
19. Henry K, Melroe H, Huebesch J. Coronary artery disease associated with protease inhibitors. Lancet 1998;351:1328
20. Anonymous. Diabetes, protease-inhibitor link unproved: Directorate. Can Med Assoc J 1997;157:502-3
21. Berger A. Protease inhibitors may cause fat abnormalities and heart disease. BMJ 1998;317:100
22. Lo JC, Mulligan K, Thai VW, Algren A, Schambelan M. Buffalo hump in men with HIV infection. Lancet 1998;351:867-70
23. Miller KD, Jones EJ, Yanovski JA, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998;351:871-5
24. Carr A, Samaras K, Burton S. Syndrome of peripheral lipodystrophy and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-8
25. Herry I, Beranard L, de Truchis P, Perronne C. Hypertrophy of the breasts in a patient treated with indinavir. Clin Infect Dis 1997;25:937-8
26. Hengel RL, Watts NB, Lennox JL. Benign symmetric lipomatosis associated with protease inhibitors. Lancet 1997;350:1596
27. Anonymous. Lipodystrophy in HIV positive patients treated with protease inhibitors. Current Problems in Pharmacovigilance. Committee Safety Med Rep 1998;24:12
28. Ball SG. The chemical pathology of AIDS. Ann Clin Biochem 1994;31:401-9
29. Henry K, Melroe H, Huebesch J, Hermundson J, Simpson J. Atorvastatin and gemfibrozil for protease inhibitor related lipid abnormalities. Lancet 1998;352:1031-2
30. Sullivan AK, Feher MD, Nelson MR, Gazzard BG. Marked hypertriglyceridaemia associated with ritonavir therapy. AIDS 1998;12:1393-4
31. Gregnon A, Angel J, Sorisky A. Protease inhibitors and adipocyte differentiation in cell culture. Lancet 1998;352:1033
32. Besson C, Jubault V, Viard JP, Praloux G. Ketoacidosis associated with protease inhibitor therapy. AIDS 1998;12:1399-400